China's ZTE Halts Major Operations Following US Export Ban
Chinese telecommunications company ZTE has halted its main operations after U.S. authorities cut off its access to American suppliers as President Donald Trump steps up pressure over trade and technology issues with Beijing.
"Major operating activities of the company have ceased" as a result of the U.S. Commerce Department "denial order" issued last month, ZTE said in a statement issued late Wednesday.
ZTE, a major supplier of telecoms networks and smartphones based in southern China, earlier said the ban threatened its existence by choking off access to U.S. suppliers of key technology and components like microchips.
The suspension came amid worsening trade tensions between the U.S. and China centered on technology-related intellectual property, though ZTE's case dates back to before President Donald Trump took office in January 2017.
A U.S. delegation traveled to Beijing last week to discuss the brewing trade conflict with their Chinese counterparts. During the meetings, Chinese officials said they also raised their objections to ZTE's punishment with the U.S. team, who they said agreed to report them to Trump.
ZTE "maintains sufficient cash and strictly adheres to its commercial obligations subject to compliance with laws and regulations," it said in the statement issued to the Hong Kong stock exchange. "The company and related parties are actively communicating with the relevant U.S. government departments in order to facilitate the modification or reversal of the Denial Order by the U.S. government and forge a positive outcome in the development of the matters."
The announcement comes days after ZTE said it had asked the Commerce Department's Bureau of Industry and Security to suspend the ban and had submitted extra information to bolster its case.
The company has more than 70,000 employees and has supplied networks or equipment to some of the world's biggest telecoms companies.
Looking for chemical products? Let suppliers reach out to you!
2026-06-24
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EU mulls expanding tariff scope on Chinese chemicals, sector-wide measures in the pipeline
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
-
U.S. Issues Final Anti-Dumping Ruling on Chinese MDI: Dumping Margins Reduced from Over 500% to 85%+
-
DKSH Expands Partnership with Assessa to Distribute Botanical Ingredients Across China
-
A Comprehensive Overview of China’s Special Engineering Materials Market: How Should the Industry Rebuild Its Capabilities Amid Growing Downstream Pressure?
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
China's Zero Tariff Policy for African Products Brings Opportunities to the Cosmetics and Personal Care Products Industry
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
Recommend Reading
-
Saint-Gobain’s Triple Acquisition: The “Small but Sophisticated” Strategy Behind Low-Carbon Building Materials
-
Bakelite Acquires Sestec, Strengthening Bio-Based Adhesives Offering
-
Air Liquide's Molybdenum Manufacturing Plant in South Korea is Operational
-
Toray Supplies Reverse Osmosis Membranes to Saudi Arabian Desalination Plant
-
Polyvantis Opens Shanghai Technical Center
-
FDA Approves Datopotamab Deruxtecan for Second Indication 45 Percent Response Rate in EGFR Mutant Lung Cancer
-
UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually
-
Over 100 Foreign Pharma Executives Join Chinese Firms in 5 Years Industry Faces Key Challenges
-
Merck’s New CMV Drug Approved in China Targets Nearly 40000 HSCT Patients
-
Shengquan Group H1 Profit Jumps 51 Percent Revenue Hits 5.35 Billion Yuan AI and EV Boom Drive New Materials Surge